Assessment of resin perfusion in hepatic failure in vitro and in vivo

World Journal of Gastroenterology

Volumn 10, Issue 6, 2004, Pages 837-840

  Wang, Ying Jie ^a   Wang, Ze Wen ^a   Luo, Bing Wei ^a   Liu, Hong Ling ^a   Wen, Hong Wei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYTOKINE; ENDOTOXIN; INTERLEUKIN 1; INTERLEUKIN 6; RESIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER PERFUSION; MALE; PLASMAPHERESIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UREA NITROGEN BLOOD LEVEL; VIRUS HEPATITIS;

EID: 1842535115     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i6.837     Document Type: Article

References (36)

1. Dowling DJ, Mutimer DJ. Artificial liver support in acute liver failure. Eur J Gastroenterol Hepatol 1999; 11: 991-996
2. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217-222
3. Stockmann HBAC, Hiemstra CA, Marquet RL, IJzermans JNM. Extracorporeal perfusion for the treatment of acute liver failure. Ann Surg 2000; 231: 460-470
4. Borra M, Galavotti D, Bellini C, Fumi L, Morsiani E, Bellini G. Advanced technology for extracorporeal liver support system devices. Int J Artif Organs 2002; 25: 939-949
5. Bertani H, Gelmini R, Del Buono MG, De Maria N, Girardis M, Solfrini V, Villa E. Literature overview on artificial liver support in fulminant hepatic failure: a methodological approach. Int J Artif Organs 2002; 25: 903-910
6. Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Ther Apher 2002; 6: 193-198
7. Ash SR, Caldwell CA, Singer GG, Lowell JA, Howard TK, Rustgi VK. Treatment of acetaminophen-induced hepatitis and fulminant hepatic failure with extracorporeal sorbent-based devices. Adv Ren Replace Ther 2002; 9: 42-53
8. Clemmesen JO, Kondrup J, Nielsen LB, Larsen FS, Ott P. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure. Am J Gastroenterol 2001; 96: 1217-1223
9. Steczko J, Bax KC, Ash SR. Effect of hemodiabsorption and sorbent-based pheresis on amino acid levels in hepatic failure. Int J Artif Organs 2000; 23: 375-388
10. Hughes RD. Review of methods to remove protein-bound substances in liver failure. Int J Artif Organs 2002; 25: 911-917
11. Di Campli C, Zileri Dal Verme L, Andrisani MC, Armuzzi A, Candelli M, Gaspari R, Gasbarrini A. Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure. Curr Med Chem 2003; 10: 341-348
12. Shito M, Balis UJ, Tompkins RG, Yarmush ML, Toner M. A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha. Dig Dis Sci 2001; 46: 1700-1708
13. Galun E, Axelrod JH. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta 2002; 1592: 345-358
14. Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, Brenner D, Manns M, Trautwein C. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000; 119: 446-460
15. Yumoto E, Higashi T, Nouso K, Nakatsukasa H, Fujiwara K, Hanafusa T, Yumoto Y, Tanimoto T, Kurimoto M, Tanaka N, Tsuji T. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002; 17: 285-294
16. Han DW. Intestinal endotoxemia as a pathogenetic mechanism in liver failure. World J Gastroenterol 2002; 8: 961-965
17. Sarnatskaya VV, Lindup WE, Walther P, Maslenny VN, Yushko LA, Sidorenko AS, Nikolaev AV, Nikolaev VG. Albumin, bilirubin, and activated carbon: new edges of an old triangle. Artif Cell Blood Substit Immobil Biotechnol 2002; 30: 113-126
18. Nakamura T, Ushiyama C, Suzuki Y, Inoue T, Shoji H, Shimada N, Koide H. Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus. J Hosp Infect 2003; 53: 58-63
19. Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R, Nakatani T. Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome. Int J Mol Med 2002; 10: 485-488
20. Sechser A, Osorio J, Freise C, Osorio RW. Artificial liver support devices for fulminant liver failure. Clin Liver Dis 2001; 5: 415-430
21. Ash SR. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 2002; 9: 3-18
22. Kramer L, Gendo A, Madl C, Ferrara I, Funk G, Schenk P, Sunder-Plassmann G, Horl WH. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. Am J Kidney Dis 2000; 36: 1193-1200
23. Musanje L, Darvell BW. Polymerization of resin composite restorative materials: exposure reciprocity. Dent Mater 2003; 19: 531-541
24. Gode F, Pehlivan E. A comparative study of two chelating ion-exchange resins for the removal of chromium(III) from aqueous solution. J Hazard Mater 2003; 100: 231-243
25. Endo Y, Shibazaki M, Yamaguchi K, Kai K, Sugawara S, Takada H, Kikuchi H, Kumagai K. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol 1999; 128: 5-12
26. Masai T, Sawa Y, Ohtake S, Nishida T, Nishimura M, Fukushima N, Yamaguchi T, Matsuda H. Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation. Ann Thorac Surg 2002; 73: 549-555
27. Rahman T, Hodgson H. Clinical management of acute hepatic failure. Intensive Care Med 2001; 27: 467-476
28. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, Korten G, Schmidt R, Hentschel J, Schulz M, Löhr M, Liebe S, Schareck W, Hopt UT. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000; 6: 603-613
29. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Löhr M, Liebe S, Schareck W, Hopt UT, Schmidt R. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999; 23: 319-330
30. Nakae H, Yonekawa C, Wada H, Asanuma Y, Sato T, Tanaka H. Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure. Ther Apher 2001; 5: 471-475
31. Nakamura T, Ushiyama C, Suzuki S, Shimada N, Ebihara I, Suzaki M, Takahashi T, Koide H. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif 2000; 18: 50-54
32. Nakae H, Asanuma Y, Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher 2002; 6: 419-424
33. Ho DW, Fan ST, To J, Woo YH, Zhang Z, Lau C, Wong J. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut 2002; 50: 869-876
34. Ryan CJ, Anilkumar T, Ben-Hamida AJ, Khorsandi SE, Aslam M, Pusey CD, Gaylor JD, Courtney JM. Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. Artif Organs 2001; 25: 109-118
35. Nakae H, Yonekawa T, Narita K, Endo S. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol 2001; 109: 65-72
36. Iwai H, Nagaki M, Naito T, Ishiki Y, Murakami N, Sugihara J, Muto Y, Moriwaki H. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med 1998; 26: 873-876